Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver

Zhen Yu, Rong Wang, Wilson C. Fok, Alexander Coles, Adam Salmon, Viviana I. Pérez

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Dietary restriction (DR) is the gold standard intervention used to delay aging, and much recent research has focused on the identification of possible DR mimetics. Energy sensing pathways, including insulin/IGF1 signaling, sirtuins, and mammalian Target of Rapamycin (mTOR), have been proposed as pathways involved in the antiaging actions of DR, and compounds that affect these pathways have been suggested to act as DR mimetics, including metformin (insulin/IGF1 signaling), resveratrol (sirtuins), and rapamycin (mTOR). Rapamycin is a promising DR mimetic because it significantly increases both health span and life span in mice. Unfortunately, rapamycin also leads to some negative effects, foremost among which is the induction of insulin resistance, potentially limiting its translation into humans. To begin clarifying the mechanism(s) involved in insulin resistance induced by rapamycin, we compared several aspects of liver metabolism in mice treated with DR or rapamycin for 6 months. Our data suggest that although both DR and rapamycin inhibit lipogenesis, activate lipolysis, and increased serum levels of nonesterified fatty acids, only DR further activates β-oxidation of the fatty acids leading to the production of ketone bodies.

Original languageEnglish (US)
Pages (from-to)410-420
Number of pages11
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume70
Issue number4
DOIs
StatePublished - Apr 1 2015
Externally publishedYes

Fingerprint

Sirolimus
Liver
Sirtuins
Insulin Resistance
Insulin
Ketone Bodies
Lipogenesis
Lipolysis
Metformin
Nonesterified Fatty Acids
Fatty Acids
Health
Serum
Research

Keywords

  • Dietary restriction
  • Metabolites
  • Rapamycin
  • β-oxidation

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver. / Yu, Zhen; Wang, Rong; Fok, Wilson C.; Coles, Alexander; Salmon, Adam; Pérez, Viviana I.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 70, No. 4, 01.04.2015, p. 410-420.

Research output: Contribution to journalArticle

Yu, Zhen ; Wang, Rong ; Fok, Wilson C. ; Coles, Alexander ; Salmon, Adam ; Pérez, Viviana I. / Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2015 ; Vol. 70, No. 4. pp. 410-420.
@article{36f44018c9d1460ca6d4c50ee76bae50,
title = "Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver",
abstract = "Dietary restriction (DR) is the gold standard intervention used to delay aging, and much recent research has focused on the identification of possible DR mimetics. Energy sensing pathways, including insulin/IGF1 signaling, sirtuins, and mammalian Target of Rapamycin (mTOR), have been proposed as pathways involved in the antiaging actions of DR, and compounds that affect these pathways have been suggested to act as DR mimetics, including metformin (insulin/IGF1 signaling), resveratrol (sirtuins), and rapamycin (mTOR). Rapamycin is a promising DR mimetic because it significantly increases both health span and life span in mice. Unfortunately, rapamycin also leads to some negative effects, foremost among which is the induction of insulin resistance, potentially limiting its translation into humans. To begin clarifying the mechanism(s) involved in insulin resistance induced by rapamycin, we compared several aspects of liver metabolism in mice treated with DR or rapamycin for 6 months. Our data suggest that although both DR and rapamycin inhibit lipogenesis, activate lipolysis, and increased serum levels of nonesterified fatty acids, only DR further activates β-oxidation of the fatty acids leading to the production of ketone bodies.",
keywords = "Dietary restriction, Metabolites, Rapamycin, β-oxidation",
author = "Zhen Yu and Rong Wang and Fok, {Wilson C.} and Alexander Coles and Adam Salmon and P{\'e}rez, {Viviana I.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1093/gerona/glu053",
language = "English (US)",
volume = "70",
pages = "410--420",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver

AU - Yu, Zhen

AU - Wang, Rong

AU - Fok, Wilson C.

AU - Coles, Alexander

AU - Salmon, Adam

AU - Pérez, Viviana I.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Dietary restriction (DR) is the gold standard intervention used to delay aging, and much recent research has focused on the identification of possible DR mimetics. Energy sensing pathways, including insulin/IGF1 signaling, sirtuins, and mammalian Target of Rapamycin (mTOR), have been proposed as pathways involved in the antiaging actions of DR, and compounds that affect these pathways have been suggested to act as DR mimetics, including metformin (insulin/IGF1 signaling), resveratrol (sirtuins), and rapamycin (mTOR). Rapamycin is a promising DR mimetic because it significantly increases both health span and life span in mice. Unfortunately, rapamycin also leads to some negative effects, foremost among which is the induction of insulin resistance, potentially limiting its translation into humans. To begin clarifying the mechanism(s) involved in insulin resistance induced by rapamycin, we compared several aspects of liver metabolism in mice treated with DR or rapamycin for 6 months. Our data suggest that although both DR and rapamycin inhibit lipogenesis, activate lipolysis, and increased serum levels of nonesterified fatty acids, only DR further activates β-oxidation of the fatty acids leading to the production of ketone bodies.

AB - Dietary restriction (DR) is the gold standard intervention used to delay aging, and much recent research has focused on the identification of possible DR mimetics. Energy sensing pathways, including insulin/IGF1 signaling, sirtuins, and mammalian Target of Rapamycin (mTOR), have been proposed as pathways involved in the antiaging actions of DR, and compounds that affect these pathways have been suggested to act as DR mimetics, including metformin (insulin/IGF1 signaling), resveratrol (sirtuins), and rapamycin (mTOR). Rapamycin is a promising DR mimetic because it significantly increases both health span and life span in mice. Unfortunately, rapamycin also leads to some negative effects, foremost among which is the induction of insulin resistance, potentially limiting its translation into humans. To begin clarifying the mechanism(s) involved in insulin resistance induced by rapamycin, we compared several aspects of liver metabolism in mice treated with DR or rapamycin for 6 months. Our data suggest that although both DR and rapamycin inhibit lipogenesis, activate lipolysis, and increased serum levels of nonesterified fatty acids, only DR further activates β-oxidation of the fatty acids leading to the production of ketone bodies.

KW - Dietary restriction

KW - Metabolites

KW - Rapamycin

KW - β-oxidation

UR - http://www.scopus.com/inward/record.url?scp=84926672210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926672210&partnerID=8YFLogxK

U2 - 10.1093/gerona/glu053

DO - 10.1093/gerona/glu053

M3 - Article

C2 - 24755936

AN - SCOPUS:84926672210

VL - 70

SP - 410

EP - 420

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 4

ER -